About Knovea
Knovea is a company. The company has 115 employees as of April 05, 2024. Knovea offers products and services including Sterile Pharmaceutical Formulations and Research and Development Services.
- Employees 115 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
- Legal Name Knovea Pharmaceutical Pvt. Limited
- Jurisdiction Indore, Madhya Pradesh, India
-
Annual Revenue
$6.88 K (USD)-99.88as on Mar 31, 2023
-
Net Profit
-$769.89 K (USD)-118.48as on Mar 31, 2023
-
EBITDA
-$719.21 K (USD)-114.1as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
115
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Knovea
Knovea offers a comprehensive portfolio of products and services, including Sterile Pharmaceutical Formulations and Research and Development Services.
Sterile pharmaceutical finished dosage forms are developed and commercialized from initial stages to market readiness
Innovation in pharmaceuticals is driven through advanced research, technology, and expertise in R&D technical services
Funding Insights of Knovea
Investments & Acquisitions by Knovea
Financial Statements - Knovea
Knovea Comparisons
Competitors of Knovea
Latest news on Knovea
Frequently Asked Questions about Knovea
As of Apr 05, 2024, the latest employee count at Knovea is 115.
Annual revenue of Knovea is $6.88K as on Mar 31, 2023.
Knovea is involved in pharmaceutical manufacturing and RD, focusing on sterile formulations and innovative delivery systems that are supported by aseptic technologies and electronic records. Established since 2004, adherence to cGMP standards and regulatory compliance is maintained to ensure products meet international quality norms. Investments in infrastructure are made to enhance affordability of medicines, while a commitment to quality, quantity, and safety is upheld through streamlined GxP processes. Collective growth is fostered by embracing expertise and nurturing teams, contributing to a healthier future.
Knovea offers Sterile Pharmaceutical Formulations and Research and Development Services.